Shareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Business WireNov 8 22:39

Sector Update: Health Care Stocks Edge Higher Premarket Friday

MT NewswiresNov 8 22:07

Sector Update: Health Care

MT NewswiresNov 8 21:52

Express News | Allovir - Upon Termination of Deal Under Specified Circumstances, Co May Be Required to Pay Kalaris Termination Fee of $3.5 Mln

BreakingsNov 8 21:41

Express News | Allovir Inc - Exchange Ratio Assumes Valuation for Allovir of $116.0 Mln and Valuation for Kalaris of $347.0 Mln

BreakingsNov 8 21:40

Rigel RIGL Analyst; Allovir ALVR Reverse Merger

BioPharmCatalystNov 8 21:30